1-6 of 6
Aasha I. Hoogland
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Trajectories of Patient-Reported Outcomes after Idecabtagene Vicleucel Vs. Ciltacabtagene Autoleucel CAR T-Cell Therapy Among Patients with Relapsed/Refractory Multiple Myeloma in Standard of Care

Xiaoyin Li, Carina E. Ferraris, Gabriel De Avila, Lisa M. Gudenkauf, Aasha I. Hoogland, Oanh Nguyen, Yvelise Rodriguez, Sylvia L. Crowder, Nathan Parker, Tiffany L. Carson, Rachid C. Baz, Kenneth H. Shain, Brandon Blue, Ariel Grajales-Cruz, Melissa Alsina, Ciara Louise Freeman, Omar Castaneda, Taiga Nishihori, Hien Liu, Frederick L. Locke, Heather S.L. Jim, Doris K. Hansen, Lauren C. Peres, Laura B. Oswald
Journal: Blood
Blood (2024) 144 (Supplement 1): 7842.
https://doi.org/10.1182/blood-2024-208668
Published: 2024
Journal Articles

Meaningful Change in Patient-Reported Outcomes after CAR T-Cell Therapy for Relapsed/Refractory Multiple Myeloma in Standard of Care: Differences By Race and Ethnicity

Carina E. Ferraris, Xiaoyin Li, Gabriel De Avila, Lisa M. Gudenkauf, Aasha I. Hoogland, Oanh Nguyen, Yvelise Rodriguez, Sylvia L. Crowder, Nathan Parker, Tiffany L. Carson, Rachid C. Baz, Kenneth H. Shain, Brandon Blue, Ariel Grajales-Cruz, Melissa Alsina, Ciara Louise Freeman, Omar Castaneda, Taiga Nishihori, Hien Liu, Frederick L. Locke, Heather S.L. Jim, Doris K. Hansen, Lauren C. Peres, Laura B. Oswald
Journal: Blood
Blood (2024) 144 (Supplement 1): 5165.
https://doi.org/10.1182/blood-2024-208529
Published: 2024
Journal Articles

Associations between Patient-Reported Outcomes and 90-Day Response to Chimeric Antigen Receptor T-Cell Therapy: A Bayesian Network Analysis

Laura B. Oswald, Yi Luo, Xiaoyin Li, Aasha I. Hoogland, Brian D. Gonzalez, Doris K. Hansen, Michael D. Jain, Frederick L. Locke, Lauren C. Peres, Kedar Kirtane, Issam El Naqa, Heather S.L. Jim
Journal: Blood
Blood (2022) 140 (Supplement 1): 10913–10915.
https://doi.org/10.1182/blood-2022-169124
Published: 2022
Journal Articles

Real-World Patient-Reported Outcomes Among Recipients of Axicabtagene Ciloleucel for Relapsed/Refractory Large B Cell Lymphoma

Heather S.L. Jim, Aasha I. Hoogland, Jennifer M. Logue, Briana Aguilar, Xiaoyin Li, Julia Thornton Snider, Sally West Wade, Christine T Fu, Julio C. Chavez, Michael D. Jain, Aleksandr Lazaryan, Bijal D. Shah, Frederick L. Locke
Journal: Blood
Blood (2022) 140 (Supplement 1): 5190–5191.
https://doi.org/10.1182/blood-2022-162337
Published: 2022
Journal Articles

Change in Patients' Perceived Cognition Among Chimeric Antigen Receptor T-Cell Therapy Recipients at Day 360

Anna Barata, Aasha I. Hoogland, Anuhya Kommalapati, Jennifer M Logue, Kelly A. Hyland, Sarah L. Eisel, Brent J. Small, Taylor Welniak, Nathaly Irizarry-Arroyo, Yvelise Rodriguez, Reena Jayani, Margaret Booth-Jones, Laura B. Oswald, Brian D. Gonzalez, Kedar Kirtane, Michael D. Jain, Sepideh Mokhtari, Julio C. Chavez, Aleksandr Lazaryan, Bijal D. Shah, Frederick L. Locke, Heather S. L. Jim
Journal: Blood
Blood (2021) 138 (Supplement 1): 3052.
https://doi.org/10.1182/blood-2021-150838
Published: 2021
Journal Articles

Patient-Reported and Neurocognitive Outcomes in Patients Treated with Axicabtagene Ciloleucel

Heather S.L. Jim, PhD, Aasha I. Hoogland, PhD, Aaron Collier, Margaret Booth-Jones, PhD, Michael D. Jain, MD PhD, Frederick L. Locke, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2289.
https://doi.org/10.1182/blood-2018-99-111711
Published: 2018